EUVIMEDEUVIMED entdecken
Leserbrief

Phase II Trial of Reduced‐Intensity Fludarabine, Melphalan, and Total Body Irradiation Conditioning With Haploidentical Donor Peripheral Blood Stem Cell Transplant

Hany Elmariah iD, Jongphil Kim, Rebecca Gonzalez, Elizabeth DiMaggio, Samer Sansil, Sean Yoder, Asmita Mishra, Rawan Faramand, Lia Perez, Aleksandr Lazaryan, Abu-Sayeef Mirza, Farhad Khimani und 10 weitere

American Journal of Hematology · 2025-09 · 100 (9) · 1665-1669

DOI: 10.1002/ajh.27738 ↗

Kurz gefasst

Leserbrief in der Zeitschrift American Journal of Hematology, online erschienen am 10.06.2025. Verfasst von Hany Elmariah und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 6 Literaturangaben. Gefördert von: NCI NIH HHS, Moffitt Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

BMThaploidenticalmarrow/stem cell transplantation‐clinical care of graft‐versus‐host diseasemelphalantransplantation

Autor:innen und Institutionen

  • Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.

ORCID-Profile: Hany Elmariah, Nelli Bejanyan

Förderung

  • NCI NIH HHS
  • Moffitt Cancer Center

Zitieren

APA

Elmariah, H., Kim, J., Gonzalez, R., DiMaggio, E., Sansil, S., Yoder, S., Mishra, A., Faramand, R., Perez, L., Lazaryan, A., Mirza, A. S., Khimani, F., Liu, H., Ochoa-Bayona, J. L., Nieder, M., Perna, F., Figura, N., Robinson, T. J., Nishihori, T., …, & Bejanyan, N. (2025). Phase II Trial of Reduced‐Intensity Fludarabine, Melphalan, and Total Body Irradiation Conditioning With Haploidentical Donor Peripheral Blood Stem Cell Transplant. American Journal of Hematology, 100(9), 1665-1669. https://doi.org/10.1002/ajh.27738

Vancouver

Elmariah H, Kim J, Gonzalez R, DiMaggio E, Sansil S, Yoder S, et al. Phase II Trial of Reduced‐Intensity Fludarabine, Melphalan, and Total Body Irradiation Conditioning With Haploidentical Donor Peripheral Blood Stem Cell Transplant. American Journal of Hematology. 2025;100(9):1665-1669. doi:10.1002/ajh.27738

BibTeX
@article{Elmariah2025,
  author = {Elmariah, Hany and Kim, Jongphil and Gonzalez, Rebecca and DiMaggio, Elizabeth and Sansil, Samer and Yoder, Sean and Mishra, Asmita and Faramand, Rawan and Perez, Lia and Lazaryan, Aleksandr and Mirza, Abu-Sayeef and Khimani, Farhad and Liu, Hien and Ochoa-Bayona, Jose L and Nieder, Michael and Perna, Fabiana and Figura, Nicholas and Robinson, Timothy J and Nishihori, Taiga and Anasetti, Claudio and Pidala, Joseph A and Bejanyan, Nelli},
  title = {Phase II Trial of Reduced‐Intensity Fludarabine, Melphalan, and Total Body Irradiation Conditioning With Haploidentical Donor Peripheral Blood Stem Cell Transplant},
  journal = {American Journal of Hematology},
  year = {2025},
  volume = {100},
  number = {9},
  pages = {1665--1669},
  doi = {10.1002/ajh.27738}
}
Kostenlos starten →